Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125613842 | 12561384 | 2 | F | 20160617 | 20160706 | 20160715 | 20160721 | EXP | DE-BFARM-16223997 | DE-ALVOGEN-2016-ALVOGEN-026098 | ALVOGEN | 62.00 | YR | M | Y | 80.00000 | KG | 20160721 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125613842 | 12561384 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 62800 | CAPSULE, HARD | |||||||||||
| 125613842 | 12561384 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | 0 | 10 | MG | ||||||||||
| 125613842 | 12561384 | 3 | SS | BISOPROLOL | BISOPROLOL | 1 | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125613842 | 12561384 | 1 | Product used for unknown indication |
| 125613842 | 12561384 | 2 | Product used for unknown indication |
| 125613842 | 12561384 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125613842 | 12561384 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125613842 | 12561384 | Brain stem infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |